Syra Health Corp
NASDAQ:SYRA
NASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)

  • LAST PRICE
    0.4102
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    0.3786/ 53
  • Ask / Lots
    0.4387/ 24
  • Open / Previous Close
    --- / 0.4102
  • Day Range
    ---
  • 52 Week Range
    0.3435
    8.3700
  • Volume
    5,399

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

Charts

Price Comparison Graph. See accessible table below
Data delayed at least 15 minutes.

Healthcare Facilities Industry Peers

CompanyMarket CapP/E Ratio (TTM)EPS Growth (5yr)
SYRA
Syra Health Corp
4.0M
-0.6x
---
GRST
Ethema Health Corp
4.6M
2.7x
---
GENE
Genetic Technologies Ltd
6.3M
-0.4x
---
CMPD
CompuMed Inc
3.7M
-21.2x
---
KDLY
Kindly MD Inc
5.1M
-1.8x
---
XCRT
Xcelerate Inc
5.5M
-9.3x
---
As of 2024-11-08

Company Information

Syra Health Corp. is a healthcare services company. The Company provides comprehensive end-to-end solutions in behavioral and mental health, population health, digital health, health education and healthcare workforce. The Company’s health education service line offers services, including medical communications, patient education, and healthcare training. Its population health management services include analytics as a service, epidemiology and health equity analytics solutions. The Company’s digital health solutions include digital transformation, cloud and security, artificial intelligence, patient engagement, and health applications. Its Syrenity is a comprehensive mental health application that provides preventative care and interventions for behavioral and mental health. It provides medical education solutions to pharmaceutical and medical device manufacturers, biotechnology companies, payers, large employers, academic institutions, and government agencies.

Contact Information

Headquarters
1119 Keystone Way N., #201CARMEL, IN, United States 46032
Phone
---
Fax
302-387-4000

Executives

Chairman of the Board, President
Sandeep Allam
Chief Executive Officer, Director
Deepika Vuppalanchi
Chief Financial Officer, Chief Operating Officer, Director
Priya Prasad
Independent Director Nominee
Andrew Dahlem
Independent Director Nominee
Ketan Paranjape

Ratings

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Reports

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals

Market Cap
$4.0M
Revenue (TTM)
$7.7M
Shares Outstanding
9.8M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-0.65
Book Value
$0.62
P/E Ratio
-0.6x
Price/Sales (TTM)
0.5
Price/Cash Flow (TTM)
---
Operating Margin
-54.89%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Calendar

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.